Abstract
Quantitative structure-activity relationships (QSARs) of various classes of antianginal drugs, e.g. nitrates, ß-adrenergic blocking agents (ß-blockers), and calcium channel blockers (calcium antagonists), have been reviewed. This review gives an overall picture of the mode of action of each class of drugs and points out the specific physicochemical and structural properties that govern their activity. It is observed that in almost all kinds of antianginal drugs the lipophilic factor plays an important role and the next important factor seems to be the steric ones. The electronic factors are found to be occasionally important. In the case of ß-blockers, the most common factor that appeared to govern the activity remained the lipophilicity. In nitrates, too, the activity is observed to primarily depend upon the lipophilicity. In calcium channel blockers, however, the dominant effect is seen to be of steric factors. The steric roles may be essential in drug-receptor interactions, which seem to involve both hydrophobic, and to a lesser extent, electronic interactions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
J.R. Parrat: Adv. Drug Res. 9, 103 (1974)
B.F. Robinson: Adv. Drug Res.1093 (1975).
R. Zelis, D.T. Mason, E.D. Amsterdom and J.F. Green, in: K.L. Melmon and A.N. Breast(eds.): Cardiovascular Drug Therapy, F.A. Davis, Philadelphia 1974, 239.
C.K. Mittal and E Murad, in: J.A. Nathansons and J.W. Kebabian (eds.): Handbook of Experimental Pharmacology, Vol. 58, Springer-Verlag, Berlin 1982, 225.
R.M. Rapaport and E Murad: J. Cyclic Nucleotide Protein Phosphorylation Res. 9, 281 (1983).
R.M. Rapaport, M.B. Draznin and F. Murad: Trans. Assoc. Am. Physicians9619 (1983).
P. Needleman, D.J. Blehm and K.S. Rostkoff: J. Pharmacol. Exp. Ther.165286 (1969).
P. Needleman and E.M. Johnson: J. Pharmacol. Exp. Ther.184709 (1973).
J.C. Krantz, Jr., in: P. Needleman (ed.): Organic Nitrates, Springer-Verlag, Berlin 1975, 1.
J.R. Parrat: Cardiovasc. Res. 3, 306 (1969).
J.R. Parrat and R.M.Wadsworth: Br. J. Pharmacol.Chemother.38554 (1970).
R.G. Shanks, in: M.M. Windbury (ed.): Problems in Laboratory Evaluation of Antiangi-nal Agents, North-Holland, Amsterdam 1967, 41.
S.P. Gupta, P. Singh and M.C. Bindal: Chem. Rev.83633 (1983).
S.P. Gupta: Chem. Rev.871183 (1987).
S.P. Gupta: Chem. Rev.891765 (1989).
S.P. Gupta: Chem. Rev.911109 (1991).
S.P.Gupta: Chem. Rev. 94, 1507 (1994)
S.P. Gupta: Prog. Drug Res. 45, 67 (1995).
S.P. Gupta: Current Pharm. Des.4455 (1998).
R. Garg, S.P. Gupta, H. Gao, M.S. Babu, C. Hansch and A.K. Debnath: Chem. Rev.993525 (1999).
S.P. Gupta: Prog. Drug Res. 53, 53 (1999).
S.P. Gupta: Prog. Drug Res. 55, 235 (2000).
E Benedini, G. Bertolini, R. Cereda, G. Donà, G. Gromo, S. Levi, J. Mizrahi and A. Sala: J. Med. Chem.38130 (1995).
J. Mizrahi, M. Bergamaschi and G. Gromo: Proc. Br. Pharmacol Soc.S16(1993).
A.M. Lands, F.P. Luduena and H.J. Buzzo: Life Sci.62241 (1967).
A.M. Lands, A. Arnold, J.P. McAuliff, F.P. Luduena and T.G. Brown: Nature (London)214597 (1967).
M. Bristow, T.R. Sherrod and R.D. Green: J. Pharmacol. Exp. Ther.17152 (1970).
J.B. Farmer and G.P. Levy: J. Pharm. Pharmacol.22145 (1970).
M.A. Washerman and B. Levy: J. Pharmacol. Exp. Ther.182256 (1972).
A.F. Crowther, R. Howe and L.H. Smith: J. Med. Chem.14511 (1971).
L.H. Smith: J. Med. Chem.191119 (1976).
L.H. Smith: J. Med. Chem.20705 (1977).
L.H. Smith: J. Med. Chem.201254 (1977).
R.H. Davies: Int. J. Quantum Chem. Quantum Biol. Symp. No.4413 (1977).
P.A. Borea, A. Bonora,V. Bertolasi and G. Gilli: Arzneim.-Forsch.301613 (1980).
B. Basil, J.R. Clark, E.C.J. Coffee, R. Jordon, A.H. Loveless, D.L. Pain and K.R.H. Wood-ridge: J. Med. Chem.19399 (1976).
G. Leclerc, A. Mann, C.-G. Wermuth, N. Bieth and J. Schwartz: J. Med. Chem.201657(1977).
H.A. Germer: J. Pharm. Pharmacol.26799 (1974).
J.P. Hieble and S. Ellis: Clin. Res.23(4), 551A (1975).
C. Petrongolo, J. Tomasi, B. Macchia and F. Macchia: J. Med. Chem.17501 (1974).
C. Petrongolo, B. Macchia, F. Macchia and A. Martinelli: J. Med. Chem.201645 (1977).
B. Macchia, F. Macchia and E Martinelli: Eur. J. Med. Chem.15515 (1980).
J.D.P. Graham and M.A. Karrar: Eur. J. Med. Chem.6103 (1963).
C. Hansch and E.J. Lien: Biochem. Pharmacol.17709 (1968).
A. Cammarata: J. Med. Chem.15573 (1972).
S.H. Unger and C. Hansch: J. Med. Chem.16745 (1973).
J.V. Levy: Eur. J. Pharmacol.2250 (1968).
J.V. Levy: J. Pharm. Pharmacol.20813 (1968).
D. Attwood and S.P. Agrawal: J. Pharm. Pharmacol.31392 (1979).
D. Hellenbrecht, B. Lemmer, G. Wiethold and H. Groberker: Naunyn Schmiedebergs Arch. Pharmacol.277211 (1973).
D. Hellenbrecht, K. F. Muller and H. Grobecker: Eur. J. Pharmacol.29223 (1974).
D. Hellenbrecht and L. Gortner: Naunyn Schmiedebergs Arch. Pharmacol.287SR32 (1975).
D. Hellenbrecht and L. Gortner: Pol. J. Pharmacol. Pharm.28625 (1976).
S.H. Unger, in: E.J. Ariëns (ed.):Drug Design, Vol. 9, Academic Press, New York 1980,47
M.S. Newman: J. Am. Chem. Soc.724783 (1950).
R. Rodenkirchen, R. Bayer, F. Steiner, H. Bossert, H. Meyer and E. Moller: Naunyn Schmiedebergs Arch. Pharmacol.31069 (1979).
R. Manhold, R. Rodenkirchen and R. Bayer: Prog. Pharmacol. 5, 25 (1982).
A. Verloop, W. Hoogenstraaten and J. Tipker, in: E. J. Ariëns (ed.): Drug Design, Vol. 7, Academic Press, New York 1976, 165.
A. Mahmoudian and G.W. Richards: J. Pharm. Pharmacol.38272 (1986).
G.T. Bolger, P. Gengo, R. Klockowski, E. Luchowski, H. Siegel, R.A. Janis, A.M. Triggle and D.J. Triggle: J. Pharmacol. Exp. Ther.225291 (1983).
R.A. Coburn, M. Wierzba, M.J. Suto, A.J. Solo, A.M. Triggle and D.J. Triggle: J. Med. Chem.312103 (1988).
A.C. Gaudio, A. Korolkovas and Y. Takahata: J. Pharm. Sci.831110 (1994).
P. Bernstein and S. Wold: Quant. Struct.-Act. Relat. 5, 45 (1986).
A. M. Triggle, E. Shefter and D. J. Triggle: J. Med. Chem.231442 (1980).
R. Fossheim, K. Svarteng, A. Mustad, C. Romming, E. Shefter and D.J. Triggle: J.Med.Chem.25126 (1982).
W. Seidel, H. Meyer, L. Born, S. Kazda and W. Dompert, in: Abstracts of Papers,187thNational Meeting of the American Chemical Society, St. Louis, 1984, ACS, Washington, DC 1984.
J.J. Baldwin, D.A. Clareman, P.K. Lumma, D.E. McClure, S.A. Rosenthal, R.J. Linguist, E.P.Faison, G.J. Kaczorowski, M.J. Trumble and G.M. Smith: J. Med. Chem.30690 (1987).
G. Rovnyak, N. Anderson, J. Gougoutas, A. Hedberg, S.D. Kimball, M. Malley, S. More-land, M. Porubcan and A. Pudzianowski: J. Med. Chem.31936 (1988).
G. Rovnyak, N. Anderson, J. Gougoutas, A. Hedberg, S.D. Kimball, M. Malley, S. More-land, M. Porubcan and A. Pudzianowski: J. Med. Chem. 34, 2521 (1991).
S. Goldman and J. Stoltefuss: Angew Chem., Int. Ed. Engl.301559 (1991).
D.J. Triggle, D.A. Langs and R.A. Janis: Med. Res. Rev. 9, 123 (1989).
G. Rovnyak, S.D. Kimball, B. Beyer, G. Cucinotta, J.D. DiMarco, J. Gougoutas, A. Hed-berg, M. Malley, J.P. McCarthy, R. Zhang and S. Moreland: J. Med. Chem.38119 (1995).
H.-D. Höltje and S. Marrer: J. Compu.-Aided Mol. Des.123 (1987).
G.T. Bolger, P.J. Gengo, E.M. Luchowski, H. Siegel, D.J. Triggle and R.A. Janis: Biochem.Biophy. Res. Commun.1041604 (1982).
K.M.M. Murphy and S.H. Snyder: Eur. J. Pharmacol. 77, 201 (1982).
C.J. Mayer, C. van Breeman and R. Casteels: Pflügers Arch.337333 (1972).
C. Cauvin, R. Loutzenhiser and C. van Breeman: Annu. Rev. Pharmacol. Toxicol.23373(1983).
A. Fleckenstein: Annu. Rev. Pharmacol. Toxicol.17149 (1997).
R.A. Janis and D.J. Triggle: J. Med. Chem.26775 (1983).
S. Papaioannou, S. Panzer-Knodle and P.-C. Yang: J. Pharmacol. Exp. Ther.24191 (1987)
R. Manhold, R. Steiner, W. Hass and R. Kaufman: Naunyn Schmiedebergs Arch. Phar-macol.302217 (1978).
E. Corelli, E Manetti, A. Tafi, G. Campiani, V. Nacci and M. Botta: J. Med. Chem.40125(1997).
G. Campiani, A. Garofalo, I. Fiorini, M. Botta, V. Nacci, A. Tafi, A. Chiarini, R. Budriesi, G. Bruni and M. R. Romeo: J. Med. Chem.384393 (1995).
S.D. Kimball, J.T. Hunt, J.C. Barrish, J. Das, D.M. Floyd, M.W. Lago, V.G. Lee, S.H. Spergel, S. Moreland, S.A. Hedberg, J.Z. Gougoutas, M.F. Malley and W.F. Lau: Bioorg. Med. Chem.1285 (1993).
D.J. Triggle: Cleveland Clin. J. Med.59617 (1992).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Basel AG
About this chapter
Cite this chapter
Gupta, S.P. (2001). Quantitative structure-activity relationships of antianginal drugs. In: Jucker, E. (eds) Progress in Drug Research. Progress in Drug Research, vol 56. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8319-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8319-1_3
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9515-6
Online ISBN: 978-3-0348-8319-1
eBook Packages: Springer Book Archive